Skip to main navigation Skip to search Skip to main content

Efficacy and safety of a fixed-dose combination of dapagliflozin and linagliptin (AJU-A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, parallel-group, placebo-controlled phase III study

  • Jun Hwa Hong
  • , Myung Jin Kim
  • , Kyung Wan Min
  • , Jong Chul Won
  • , Tae Nyun Kim
  • , Byung Wan Lee
  • , Jun Goo Kang
  • , Jae Hyeon Kim
  • , Jung Hwan Park
  • , Bon Jeong Ku
  • , Chang Beom Lee
  • , Sang Yong Kim
  • , Ho Sang Shon
  • , Woo Je Lee
  • , Joong Yeol Park
  • Eulji University
  • University of Ulsan
  • Inje University
  • Yonsei University
  • Hallym University
  • Hanyang University
  • Chungnam National University
  • Chosun University
  • Catholic University of Daegu

Research output: Contribution to journal › Article › peer-review

3   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of a fixed-dose combination of dapagliflozin and linagliptin (AJU-A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, parallel-group, placebo-controlled phase III study'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry